# P. Andrew Futreal

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/p-andrew-futreal/

## Facts

| Field | Value |
| --- | --- |
| Citations | 168,167 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 161 |
| i10-index | 421 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5067102201 |
| ORCID iD | https://orcid.org/0000-0001-8663-2671 |
| Works | 1,364 |

## Researcher papers

Showing 12 of 16.

- [Signatures of mutational processes in human cancer](https://scholariq.org/papers/signatures-of-mutational-processes-in-human-cancer/)
- [Systematic identification of genomic markers of drug sensitivity in cancer cells](https://scholariq.org/papers/systematic-identification-of-genomic-markers-of-drug-sensitivity-in-cancer-cells/)
- [International network of cancer genome projects](https://scholariq.org/papers/international-network-of-cancer-genome-projects/)
- [Landscape of somatic mutations in 560 breast cancer whole-genome sequences](https://scholariq.org/papers/landscape-of-somatic-mutations-in-560-breast-cancer-whole-genome-sequences/)
- [AACR Project GENIE: Powering Precision Medicine through an International Consortium](https://scholariq.org/papers/aacr-project-genie-powering-precision-medicine-through-an-international/)
- [The landscape of cancer genes and mutational processes in breast cancer](https://scholariq.org/papers/the-landscape-of-cancer-genes-and-mutational-processes-in-breast-cancer/)
- [Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts](https://scholariq.org/papers/somatic-i-sf3b1-i-mutation-in-myelodysplasia-with-ring-sideroblasts/)
- [A small-cell lung cancer genome with complex signatures of tobacco exposure](https://scholariq.org/papers/a-small-cell-lung-cancer-genome-with-complex-signatures-of-tobacco-exposure/)
- [Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing](https://scholariq.org/papers/intratumor-heterogeneity-in-localized-lung-adenocarcinomas-delineated-by/)
- [Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities](https://scholariq.org/papers/co-occurring-genomic-alterations-define-major-subsets-of-i-kras-i-mutant-lung/)
- [Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial](https://scholariq.org/papers/neoadjuvant-nivolumab-or-nivolumab-plus-ipilimumab-in-operable-non-small-cell/)
- [Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance](https://scholariq.org/papers/pan-cancer-t-cell-atlas-links-a-cellular-stress-response-state-to-immunotherapy/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.